300750 Contemporary Amperex Technology (A)

DGAP-News: Asterion Appoints John Wagner as Strategic Advisor

DGAP-News: Asterion Cannabis Inc. / Key word(s): Miscellaneous
Asterion Appoints John Wagner as Strategic Advisor

29.05.2019 / 14:02
The issuer is solely responsible for the content of this announcement.


Vancouver, British Columbia--(Newsfile Corp. - May 29, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company") and Asterion Australia Pty Ltd ("Asterion Australia"), the Company's wholly-owned subsidiary, announces that Asterion Australia has entered into a strategic advisory services agreement with Mr. John Wagner, a Non-Executive Director of Wagners Holding Company Limited (ASX: WGN) ("Wagners"). Pursuant to the agreement, Mr. Wagner has been appointed as a Strategic Advisor to the Board of Directors of Asterion Australia and Asterion's Chief Executive Officer.

Mr. Wagner is one of the co-founders of Wagners and has been involved with Wagners since its inception. He has been instrumental in developing Wagners into one of the leading construction materials producers in South East Queensland. Mr. Wagner is also the inaugural Chair of Darling Downs Tourism and was the inaugural chair of the Toowoomba and Surat Basin Enterprises.

Wagners had a significant role in assisting Asterion and Asterion Australia in securing the appropriate piece of land in Toowoomba, Australia on which to construct and house approximately 40 hectares (99 acres) of cutting-edge, secure, purpose-built greenhouses for the production of high-quality medicinal cannabis (the "Queensland Facility").

Mr. John Wagner commented, "I am very pleased to support Asterion and its plans to develop a state of the art facility at Wellcamp Airport, it is an exciting opportunity and one that will bring many economic benefits to the region."

Asterion's Chairman and CEO, Mr. Stephen Van Deventer commented, "We are extremely pleased to have established a strong following of support from Wagners. They are globally recognized as one of Queensland's largest construction materials and service providers who add value across several industries. Having John Wagner as an advisor will assist in fostering long-term and deeply-rooted community and strategic relationships for Asterion in Australia."

About Wagners

Wagners is an Australian company focused on the production and sale of construction materials. Wagners is an innovative service provider and a producer of new generation building materials. From a foundation as an independently owned company nearly 30 years ago in Toowoomba, Australia, Wagners is now an ASX-listed operator in domestic and international markets and one of Queensland's largest construction materials and mining services companies.

The Wagner family developed the Toowoomba Wellcamp Airport, the first public airport to be constructed in Australia in 50 years. It was built entirely with private money and completed in less than 20 months. Toowoomba Wellcamp Airport has become a thriving international airport and a regional international gateway.

In 2009, Wagners was acknowledged by the Premier of Queensland at the Smart Business Awards as the company that had made the most significant impact on regional Queensland in the state's 150-year history. In 2018 Wagners was inducted into the Queensland Business Leaders Hall of Fame in recognition of their intrepid entrepreneurship in successfully completing highly challenging infrastructure projects nationally and internationally.

Celebrating 30 years of operations, Wagners is constantly striving for innovative, effective and economic solutions, when supplying for the construction and mining industry both within Australia and internationally.

About Asterion

Asterion is a Canadian medicinal cannabis company with operations in Australia, specializing in medical cannabis and is focused on becoming an industry leader in next-generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality of genetically uniform cannabis strains, at an affordable price.

The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.

On Behalf of the Board of Directors

"Stephen Van Deventer"
Chairman & Chief Executive Officer

For further information, please contact:

Deanna Kress

Forward-Looking Statements:

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future including, without limitation, the advisory services to be provided by John Wagner, the construction of the Queensland Facility, the Company's anticipated business plans, and its prospect of success in executing its proposed plans. Often, but not always, forward-looking statements can be identified by words such as "will", "plans", "expects", "may", "intends", "anticipates", "believes", "proposes", "estimates" or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Forward looking statements are based on certain assumptions regarding the Company, including that the Company will be able to obtain the financing and approvals needed to build the Queensland Facility and to carry out its planned future activities. Actual results could differ from those projected in any forward-looking statements due to numerous factors including, but not limited to, the inability of the Company and Asterion Australia to obtain the required approvals for the construction and operation of the Queensland Facility, execute its proposed business plans and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, changes in general economic conditions, changes in the financial markets and in the demand and market price for cannabis, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company. These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time.

Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.

45115_7694c460e4f6f863_logo.jpg

To view the source version of this press release, please visit

newsinfo.php?i=45115&f=169

Click on, or paste the following link into your web browser,to view the associated documents /release/45115


29.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Asterion Cannabis Inc.
Canada
EQS News ID: 817191

 
End of News DGAP News Service

817191  29.05.2019 

fncls.ssp?fn=show_t_gif&application_id=817191&application_name=news&site_id=research_pool
EN
29/05/2019

Underlying

300750Contemporary Amperex Technology (A)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Contemporary Amperex Technology (A)

 PRESS RELEASE

DGAP-News: ADL Bionatur Solutions Wins New Fermentation Client With Co...

DGAP-News: ADL Bionatur Solutions / Key word(s): Agreement ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million 02.12.2019 / 09:06 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS WINS NEW FERMENTATION CLIENT WITH CONTRACT REVENUES OF EUR 20 MILLION The agreement with a leading Swiss biotech company includes technology transfer, upscaling and industrial-scale production of high value-added innovative ingredients for the cosmetics and nutrition industry ADL to apply its expertise in a...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: Dozens Savings Plc 5.00% Secured Bonds due 2 December 2020 ISIN: GB00BL1GTZ11  Symbol: DS04 EMS: 1 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   W...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: SAPO PLC Ordinary Shares of GBP 0.01 ISIN: GB00B16GQJ90 Symbol: SAPO EMS: 5000 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   Website: ...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publishes open letter to Dr. Martin Haefner...

EQS Group-News: Dynamics Group AG / Key word(s): Statement/Corporate Action LIWET HOLDING AG publishes open letter to Dr. Martin Haefner in various Swiss Sunday newspapers 01.12.2019 / 05:59 Open letter to Dr. Martin Haefner Dear Mr Haefner We share your concern about the future of Schmolz+Bickenbach (S+B). The company urgently needs money, everyone - including Liwet - agrees. However, there is still time to find a constructive solution for S+B that is in the interest of all, not only one particular shareholder. Liwet is ready to rescue the company and the 10,000 jobs. Liw...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haef...

EQS Group-News: Dynamics Group AG / Schlagwort(e): Stellungnahme/Kapitalmaßnahme LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haefner in verschiedenen Schweizer Sonntagszeitungen 01.12.2019 / 05:59 Offener Brief an Dr. Martin Haefner Sehr geehrter Herr Haefner Wir teilen Ihre Sorge um die Zukunft von Schmolz+Bickenbach (S+B). Die Firma braucht dringend Geld; damit sind alle - auch Liwet - einverstanden. Noch bleibt Zeit, um eine konstruktive Lösung für S+B zu finden, die im Interesse aller Aktionäre ist, nicht nur eines einzigen. Liwet steht bereit, die Fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch